| 51 |
24308644 | Prevalence of persistent lipid abnormalities in statin-treated patients: Belgian results of the Dyslipidaemia International Study (DYSIS). | 2014 Feb |
1 |
| 52 |
24528691 | Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease. | 2014 Jan-Feb |
3 |
| 53 |
24725763 | Rationale and design of a randomized clinical study to investigate the effect of ezetimibe, a cholesterol absorption inhibitor, on the regression of intracoronary plaque evaluated by non-obstructive angioscopy and ultrasound: The ZIPANGU study. | 2014 Dec |
2 |
| 54 |
24734885 | Population pharmacodynamic analysis of LDL-cholesterol lowering effects by statins and co-medications based on electronic medical records. | 2014 Oct |
1 |
| 55 |
25037695 | Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: results of a 24 week, double-blind, randomized Phase 3 trial. | 2014 Sep |
1 |
| 56 |
25089134 | Influence of previous statin therapy on cholesterol-lowering effect of ezetimibe. | 2014 Jul |
2 |
| 57 |
25091271 | Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe. | 2014 Sep |
1 |
| 58 |
25463129 | Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis. | 2014 Dec |
3 |
| 59 |
23603824 | Differences in action of atorvastatin and ezetimibe in lowering low-density lipoprotein cholesterol and effect on endothelial function: randomized controlled trial. | 2013 |
1 |
| 60 |
24094079 | RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale. | 2013 Oct 5 |
2 |
| 61 |
24222265 | Recent developments in the treatment of familial hypercholesterolemia: a review of several new drug classes. | 2013 Dec |
1 |
| 62 |
24265554 | Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy. | 2013 |
6 |
| 63 |
24454328 | Is combined lipid-regulating therapy safe and feasible for the very old patients with mixed dyslipidemia? | 2013 Dec |
1 |
| 64 |
22442891 | [Statin-ezetimibe combination in hyperlipidemia treatment]. | 2012 |
3 |
| 65 |
22659533 | Double-dose pravastatin versus add-on ezetimibe with low-dose pravastatin - effects on LDL cholesterol, cholesterol absorption, and cholesterol synthesis in Japanese patients with hypercholesterolemia (PEAS study). | 2012 |
4 |
| 66 |
23040830 | Effects of ezetimibe added to statin therapy on markers of cholesterol absorption and synthesis and LDL-C lowering in hyperlipidemic patients. | 2012 Dec |
4 |
| 67 |
21255539 | Ezetimibe is effective in the treatment of persistent hyperlipidemia of renal allograft recipients. | 2011 Feb |
3 |
| 68 |
21262787 | Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9. | 2011 Apr |
1 |
| 69 |
21349260 | Switching from statin monotherapy to ezetimibe/simvastatin or rosuvastatin modifies the relationships between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients at high risk of coronary disease. | 2011 Jun |
3 |
| 70 |
21473671 | Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysis. | 2011 Jun |
4 |
| 71 |
21497705 | Combination therapy with ezetimibe/simvastatin versus statin monotherapy for low-density lipoprotein cholesterol reduction and goal attainment in a real-world clinical setting. | 2011 Feb |
1 |
| 72 |
21519514 | Comparison of Ezetimibe/Simvastatin 10/20 mg Versus Atorvastatin 20 mg in Achieving a Target Low Density Lipoprotein-Cholesterol Goal for Patients With Very High Risk. | 2011 Mar |
2 |
| 73 |
21663647 | Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART). | 2011 Jun 10 |
1 |
| 74 |
21699369 | Begin with the real-world patients of non-goal-achieved hypercholesterolemia in taiwan through the ezetimibe/simvastatin tablet - The BRAVO Study. | 2011 Aug |
2 |
| 75 |
22291820 | Effectiveness and tolerability of ezetimibe co-administered with statins versus statin dose-doubling in high-risk patients with persistent hyperlipidemia: The EZE(STAT)2 trial. | 2011 Oct |
1 |
| 76 |
19770669 | Pleiotropic effects with equivalent low-density lipoprotein cholesterol reduction: comparative study between simvastatin and simvastatin/ezetimibe coadministration. | 2010 Jan |
2 |
| 77 |
19828909 | Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial. | 2010 Apr |
1 |
| 78 |
19965915 | Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin. | 2010 Feb |
2 |
| 79 |
20075600 | The effects of ezetimibe on surrogate markers of cholesterol absorption and synthesis in Japanese patients with dyslipidemia. | 2010 Feb |
3 |
| 80 |
20155988 | Efficacy and safety of ezetimibe for Japanese patients with dyslipidaemia: The ESSENTIAL Study. | 2010 |
6 |
| 81 |
20199786 | Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe. | 2010 Jun |
1 |
| 82 |
20487050 | Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets. | 2010 Jul |
1 |
| 83 |
20880342 | Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events. | 2010 Nov |
1 |
| 84 |
20885068 | Efficacy and safety of ezetimibe in patients undergoing hemodialysis. | 2010 |
3 |
| 85 |
21090830 | The cost effectiveness of statin therapies in Spain in 2010, after the introduction of generics and reference prices. | 2010 |
1 |
| 86 |
21348380 | Efficacy and safety of ezetimibe and low-dose simvastatin as primary treatment for dyslipidemia in peritoneal dialysis patients. | 2010 |
1 |
| 87 |
18353459 | The impact of ezetimibe and high-dose of statin treatment on LDL levels in patients with heterozygous familial hypercholesterolemia. | 2009 May 15 |
2 |
| 88 |
19192988 | Perspectives on low-density lipoprotein cholesterol goal achievement. | 2009 Feb |
1 |
| 89 |
19217513 | Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety. | 2009 Mar |
2 |
| 90 |
19230898 | Ezetimibe treatment of pediatric patients with hypercholesterolemia. | 2009 Jun |
4 |
| 91 |
19262375 | Statin and ezetimibe combination therapy in cardiovascular disease. | 2009 Apr |
3 |
| 92 |
19721860 | The efficacy and safety of ezetimibe and low-dose simvastatin as a primary treatment for dyslipidemia in renal transplant recipients. | 2009 Sep |
3 |
| 93 |
19997842 | [Achievement of blood lipid target levels with Ezetimibe/Simvastatin in patients with atherosclerosis and/or diabetes mellitus--an Austrian observational study]. | 2009 |
1 |
| 94 |
18343245 | Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study. | 2008 Jan |
3 |
| 95 |
18485273 | Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation. | 2008 May |
4 |
| 96 |
18837641 | Ezetimibe 5 and 10 mg for lowering LDL-C: potential billion-dollar savings with improved tolerability. | 2008 Oct |
3 |
| 97 |
19159125 | Cost effectiveness of ezetimibe in patients with cardiovascular disease and statin intolerance or contraindications: a Markov model. | 2008 |
5 |
| 98 |
21291712 | Effect of ezetimibe/simvastatin vs atorvastatin on lowering levels of LDL-C and non-HDL-C, ApoB, and hs-CRP in patients with type 2 diabetes. | 2008 Feb |
1 |
| 99 |
21291777 | Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein. | 2008 Dec |
1 |
| 100 |
17252094 | Ezetimibe added to statin therapy (EASY study) - an evaluation by Australian general practitioners. | 2007 Jan-Feb |
1 |